Precision-medicine diagnostics, tracking and analytics for better patient outcomes.
Stress & anxiety category is set to be the second-fastest-growing category.
According to the World Health Organization…
Nearly 1 in 3 people aged 13 to 18 will experience an anxiety disorder at some point.
COVID-19 pandemic triggered a 25% increase in the prevalence of anxiety and depression worldwide.
Be a MUJN partner.
Thank you for your interest in our diagnostics for better brain health.
Our suite of products are available only through health clinics.
Please fill out the following form, and a sales representative will contact you promptly.
© 2023 MUJN Diagnostics Inc.
A PanGenomic Health Inc. Company